Skip to content

Targeted-sequencing of PTC in Different Stages

Targeted-sequencing of PTC in Different Stages

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03214978
Acronym
PTC
Enrollment
80
Registered
2017-07-12
Start date
2017-07-30
Completion date
2017-12-31
Last updated
2017-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exploratory Study

Keywords

thyroid

Brief summary

The prevalence of papillary thyroid micro-carcinoma (PTMC) increased rapidly in recent years but the design of treatment is controversial because a majority of them are indolent. Therefore, to recognize which PTMC is of strong progressive potential which should be operated is very crucial. Fine needle aspiration (FNA) pre-surgery could obtain tumor cells which could be used in genetic analysis. To date, there is no specific way to evaluate the aggressive potential of a PTMC pre-surgery. So, the purpose of this proposal is to screen genetic mutations of the aggressive type of PTMC. The candidate did a whole exome sequencing on 3-3 pairs of PTCs and found some SNPs and Indels in TP53、TTN、PDF. To further investigate those mutations, a target region sequencing will be done in 40 pairs tumor samples. And ultimately to find out which genetic event could contribute to strong aggressive potential of PTC. The mutations details would be design to test the FNA and tissue sample to validate if the genetic testing based on FNA is reliable. The gene test results would be evaluated with sonographic features to predict the potential of small thyroid carcinoma before surgery. This project won't aim to study the function and mechanism of specific genes but just screen them out. So, the fund would cover the fee of the whole study and this study is very likely to achieve the goal.

Interventions

None listed

Sponsors

Shanghai 6th People's Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients who will receive thyroid resection

Exclusion criteria

* patients who has been radiologically treated

Design outcomes

Primary

MeasureTime frameDescription
types of mutation of targets genes in papillary thyroid carcinomas in different stages2018-1-1types of mutation of targets genes in papillary thyroid carcinomas in different stages

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026